Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab [1]

Journal of Rheumatology

Volumn 34, Issue 11, 2007, Pages 2313-2314

  Sturfelt, Gunnar ^a   Christensson, Bertil ^a   Bynke, Gunnel ^a   Saxne, Tore ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CYCLOSPORIN A; GOLD; INFLIXIMAB; METHOTREXATE; PENTETREOTIDE IN 111; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CLINICAL EXAMINATION; DRUG DOSE TITRATION; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL HYPERTENSION; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SARCOIDOSIS;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35948987607     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (19)

1. Moller DR. Treatment of sarcoidosis: from a basic science point of view. J Intern Med 2003;253:31-40.
2. Symmons DPM, Silman AJ. The world of biologics. Lupus 2006;15:122-6.
3. Furst DE, Breedfeld FC, Kalden JR, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases. Ann Rheum Dis 2006;65 Suppl:iii2-15.
4. White ES, Lynch JP. Pharmacological therapy for Wegener's granulomatosis. Drugs 2006;66:1209-28.
5. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 2003;30:1864-7.
6. Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum 2005;53:788-91.
7. Baughman RP, Lower EL, Bradley DA, Raymond LA, Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized study. Chest 2005;128:1062-7.
8. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006;174:795-802.
9. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum 2006;55:978-81.
10. Almodovar R, Izquierdo M, Zarco P, Javier Quiros F, Mazzucchelli R, Steen B. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol 2007;25:99-101.
11. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 2007 Mar 6; Epub ahead of print.
12. Kudrin A, Chilvers ER, Ginawi A, et al. Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol 2007;34:648-9.
13. Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC, Fernandez-Llaca H, Rodriguez-Valverde V. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2006;55:817-20.
14. Fallahi S, Collins D, Miller RK, Halla JT. Coexistence of rheumatoid arthritis and sarcoidosis: difficulties encountered in the differential diagnosis of common manifestations. J Rheumatol 1984;11:526-9.
15. Marotte H, Charrin EC, Miossec P. Infliximab-induced aseptic meningitis. Lancet 2001;358:1784.
16. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003;289:3300-3.
17. Mangiapan G, Hance A. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995;12:20-37.
18. Yamada T, Eishi Y, Ikeda S, et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 2002;198:541-7.
19. Nilsson K, Pahlson C, Lukinius A, Eriksson L, Nilsson L, Lindquist O. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 2002; 185:1128-38.